This site uses cookies to ensure the best viewing experience for our readers.
Genetic Crop Design Company Evogene Appoints Former Bayer Exec to Board

Brief

Genetic Crop Design Company Evogene Appoints Former Bayer Exec to Board

Nasdaq and Tel Aviv-listed Evogene uses computational predictive biology to develop novel crop strains and pesticides

CTech | 15:16, 04.02.19
Israel-based genetic crops design company Evogene Ltd. has announced on Monday the appointment of agtech veteran Adrian Percy to its board of directors.

Nasdaq and Tel Aviv-listed Evogene uses computational predictive biology to develop novel crop strains and pesticides, in a variety of related domains, including agricultural chemicals, agricultural biological, and human microbiome-based therapeutics. The company routinely collaborates with market leaders, including German multinational Bayer AG.

Percy, who holds a biochemistry PhD from the University of Birmingham, has until recently served as the head of research and development for Bayer's crop science division, and as a member of its executive committee.

Cotton. Photo: Bloomberg Cotton. Photo: Bloomberg Cotton. Photo: Bloomberg

share on facebook share on twitter share on linkedin share on whatsapp share on mail

TAGS